Patients with metastatic or advanced cancer treated in practices that have high rates of giving systemic care in the last 2 weeks of life do not have longer survival rates than patients in practices that have low rates of such care.may help reassure oncologists that giving systemic anticancer therapy at the most advanced stages of cancer will not improve the patient's life, the authors wrote.
But the metric has been criticized because it focuses only on people who died and not people who lived longer because they benefited from the systemic therapy, the authors wrote. This study included not just chemotherapy, as some other studies have, but targeted therapies and immunotherapies as well. Dr Adelson said some think that the newer drugs might change the prognosis at end of life. But this study shows"even those drugs are not helping patients to survive with very advanced cancer," she said.
Source: Healthcare Press (healthcarepress.net)
Lung Carcinoma Cancer Of The Lung Palliative Care Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Advanced Cancer Biologic Therapy Biologics Small Cell Lung Cancer Small-Cell Lung Cancer Oat Cell Lung Cancer SCLC Malignant Kidney Neoplasm Renal Cell Cancer RCC - Renal Cell Carcinoma Cancer Of The Kidney Renal Cell Carcinoma RCC Targeted Therapy
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Medscape - 🏆 386. / 55 Read more »
Source: Medscape - 🏆 386. / 55 Read more »
Source: CNBC - 🏆 12. / 72 Read more »
Source: Medscape - 🏆 386. / 55 Read more »
Source: IntEngineering - 🏆 287. / 63 Read more »
Source: NBCLA - 🏆 319. / 59 Read more »